drugset / Trial / NCT00630279
Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to estimate the efficacy of a number of doses in patients with pancreatic insufficiency
Timeline
- Start
- 2008-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Outcome
Outcome not reported
Stopped: “This trial discontinued March 7,2009 due to high screen failure rate.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLV339 | Protein / enzyme biologic | 150 mg | Oral |
| Subject | SLV339 | Protein / enzyme biologic | 300 mg | Oral |
| Subject | SLV339 | Protein / enzyme biologic | 600 mg | Oral |